Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Slavisa, Tubin"'
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 44, Iss , Pp 100691- (2024)
Spatially Fractionated Radiation Therapy (SFRT) is a form of radiotherapy that delivers a single large dose of radiation within the target volume in a heterogeneous pattern with regions of peak dosage and regions of under dosage. SFRT types can be de
Externí odkaz:
https://doaj.org/article/863e379c5d6e46b2a5d0565d37eac1e2
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Maciej J. Pelak, Birgit Flechl, Eugen Hug, Razvan Galalae, Lisa Konrath, Joanna Góra, Piero Fossati, Carola Lütgendorf-Caucig, Slavisa Tubin, Rastko Konstantinovic, Ulrike Mock, Christoph Fussl, Petra Georg
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
AimData on the safety of moderately hypofractionated proton beam therapy (PBT) are limited. The aim of this study is to compare the acute toxicity and early quality of life (QoL) outcomes of normofractionated (nPBT) and hypofractionated PBT (hPBT).Ma
Externí odkaz:
https://doaj.org/article/74a9c62c6ea74555ae50b32301f2528d
Autor:
Jun Yang, Qiuxia Lu, Weihua Qi, Kolb, Ryann D., Lei Wang, Yuan Li, Sida Li, Yihui Lin, Jiayi Liu, Mourad, Waleed, MirkhaghaniHaghighi, Farzaneh, Slavisa, Tubin, Xiaodong Wu, Wei-Ciang You, Eddy Yang, Hanlon, Alex, Zhu, Alan, Weisi Yan
Publikováno v:
Frontiers in Oncology; 2024, p1-11, 11p
Autor:
Rosario Mazzola, Barbara Alicja Jereczek-Fossa, Davide Franceschini, Slavisa Tubin, Andrea Riccardo Filippi, Maria Tolia, Andrea Lancia, Giuseppe Minniti, Stefanie Corradini, Stefano Arcangeli, Marta Scorsetti, Filippo Alongi
Publikováno v:
Radiation Oncology, Vol 15, Iss 1, Pp 1-13 (2020)
Abstract Background During these last years, new agents have dramatically improved the survival of the metastatic patients. Oligometastases represent a continuous field of interest in which the integration of metastases-directed therapy and drugs cou
Externí odkaz:
https://doaj.org/article/c0301203d9194c2bbd78bd76d429581b
Publikováno v:
Radiation Oncology, Vol 14, Iss 1, Pp 1-7 (2019)
Abstract Background A novel unconventional SBRT-based PArtial Tumor irradiation targeting HYpoxic clonogenic cells (SBRT-PATHY) for induction of the tumoricidal bystander (BE) and abscopal effects (AE) was developed by translating our preclinical fin
Externí odkaz:
https://doaj.org/article/5b2e4b3cb40c4baaad78f68d72e80c00
Autor:
Slavisa Tubin, Mohammad K. Khan, Gerardo Salerno, Waleed F. Mourad, Weisi Yan, Branislav Jeremic
Publikováno v:
Radiation Oncology, Vol 14, Iss 1, Pp 1-11 (2019)
Abstract Background Radiotherapy-induced lymphopenia may be limiting the success of therapy and could also negatively affect the ability of immune system in mediating the bystander (BE) and abscopal effects (AE). A novel SBRT-based PArtial Tumor irra
Externí odkaz:
https://doaj.org/article/5b847dc57c0543e98a53ec38f05affbd
Publikováno v:
Radiation Oncology, Vol 14, Iss 1, Pp 1-11 (2019)
Abstract Background Despite the advances in oncology, patients with bulky tumors have worse prognosis and often receive only palliative treatments. Bulky disease represents an important challenging obstacle for all currently available radical treatme
Externí odkaz:
https://doaj.org/article/82722ab24edf40469ac72f314976039c
Autor:
Slavisa Tubin, Piero Fossati, Ulrike Mock, Carola Lütgendorf-Caucig, Birgit Flechl, Maciej Pelak, Petra Georg, Christoph Fussl, Antonio Carlino, Markus Stock, Eugen Hug
Publikováno v:
Cancers; Volume 15; Issue 7; Pages: 2093
Background: Skull base chordomas are radio-resistant tumors that require high-dose, high-precision radiotherapy, as can be delivered by particle therapy (protons and carbon ions). We performed a first clinical outcome analysis of particle therapy bas
Autor:
Slavisa Tubin, Piero Fossati, Antonio Carlino, Giovanna Martino, Joanna Gora, Markus Stock, Eugen Hug
Publikováno v:
Cancers; Volume 14; Issue 9; Pages: 2232
Background: We present the early results of a novel partial bulky-tumor irradiation using particles for patients with recurrent unresectable bulky tumors who failed previous state-of-the-art treatments. Methods: First, eleven consecutive patients wer